Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Long Non-Coding Rna Signatures in Lymphopoiesis and Lymphoid Malignancies Publisher



Baghdadi H1 ; Heidari R2, 3 ; Zavvar M4 ; Ahmadi N5 ; Shakouri Khomartash M3 ; Vahidi M1, 3 ; Mohammadimehr M1, 3 ; Bashash D5 ; Ghorbani M1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Laboratory Sciences, School of Allied Medical Sciences, AJA University of Medical Sciences, Tehran, 1411718541, Iran
  2. 2. Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, 1411718541, Iran
  3. 3. Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, 1411718541, Iran
  4. 4. Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, 443614177, Iran
  5. 5. Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, 1985717443, Iran

Source: Non-coding RNA Published:2023


Abstract

Lymphoid cells play a critical role in the immune system, which includes three subgroups of T, B, and NK cells. Recognition of the complexity of the human genetics transcriptome in lymphopoiesis has revolutionized our understanding of the regulatory potential of RNA in normal lymphopoiesis and lymphoid malignancies. Long non-coding RNAs (lncRNAs) are a class of RNA molecules greater than 200 nucleotides in length. LncRNAs have recently attracted much attention due to their critical roles in various biological processes, including gene regulation, chromatin organization, and cell cycle control. LncRNAs can also be used for cell differentiation and cell fate, as their expression patterns are often specific to particular cell types or developmental stages. Additionally, lncRNAs have been implicated in lymphoid differentiation, such as regulating T-cell and B-cell development, and their expression has been linked to immune-associated diseases such as leukemia and lymphoma. In addition, lncRNAs have been investigated as potential biomarkers for diagnosis, prognosis, and therapeutic response to disease management. In this review, we provide an overview of the current knowledge about the regulatory role of lncRNAs in physiopathology processes during normal lymphopoiesis and lymphoid leukemia. © 2023 by the authors.
Other Related Docs
10. Long Non-Coding Rnas As Epigenetic Regulators in Cancer, Current Pharmaceutical Design (2019)
13. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)